Search Within

Alexandra G Jacob

Formats
  1. Meeting Abstract (6)
  2. Journal Article (1)
Groups
  1. Department of Medicine (7)
  2. Hematologic Malignancies, Division of (7)
  3. Biostatistics Service (6)
  4. Center for Hematologic Malignancies (6)
  5. Epidemiology and Biostatistics (6)
  6. Survivorship Research (6)

More Groups

People
  1. Andromachi Scaradavou (4)
  2. Doris Ponce (4)
  3. Gunjan Shah (4)
  4. Ioannis Politikos (4)
  5. Juliet Barker (4)
  6. Kristine Naputo (4)

More People

Years
  1. 2018 (3)
  2. 2017 (1)
  3. 2016 (1)
  4. 2014 (2)
Publications
  1. Blood (4)
  2. Biology of Blood and Marrow Transplantation (3)
Publishers
  1. American Society of Hematology (4)
  2. Elsevier Inc. (3)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Analysis of cytomegalovirus (CMV) infections in the first 180 days in adult sero-positive cord blood transplantation (CBT) recipients reveals high infection rates and treatment burden
    Meeting Abstract

    Lau, C.; Politikos, I.; Devlin, S. M.; Jacob, A. G.; Maloy, M.; Naputo, K.; Afuye, A.; Bhatt, V.; Dahi, P. B.; Perales, M. A.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Long-term follow-up of adult double unit cord blood (CB) transplantation (dCBT) recipients reveals high rates of progression-free survival after a novel Cy/ Flu/ Thio/ TBI 400 intermediate intensity conditioning regimen
    Meeting Abstract

    Politikos, I.; Devlin, S. M.; Jacob, A. G.; Maloy, M.; Mazis, C.; Naputo, K.; Afuye, A.; Scaradavou, A.; O'Reilly, R. J.; Avecilla, S. T.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Therapeutic cyclosporine-a (CSA) levels in the first 7 days after cord blood transplantation (CBT) are critical to prevent severe acute graft-versus-host disease (aGVHD)
    Meeting Abstract

    Bhatt, V.; Politikos, I.; Devlin, S. M.; Jacob, A. G.; Maloy, M.; Naputo, K.; Afuye, A.; Scaradavou, A.; O'Reilly, R. J.; Castro-Malaspina, H.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Long-term follow-up of adult double unit cord blood (CB) transplantation (dCBT) recipients reveals high rates of progression-free survival after a novel cy/flu/thio/TBI 400 intermediate intensity conditioning regimen
    Meeting Abstract

    Politikos, I.; Devlin, S. M.; Jacob, A.; Maloy, M.; Mazis, C.; Naputo, K.; Scaradavou, A.; O'Reilly, R.; Avecilla, S.; Castro-Malaspina, H. R.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma
    Journal Article

    Kumar, A.; Casulo, C.; Yahalom, J.; Schòˆder, H.; Barr, P. M.; Caron, P.; Chiu, A.; Constine, L. S.; Drullinsky, P.; Friedberg, J. W.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • PD-1 blockade with the monoclonal antibody pembrolizumab (MK-3475) in patients with classical Hodgkin lymphoma after brentuximab vedotin failure: Preliminary results from a phase 1b study (KEYNOTE-013)
    Meeting Abstract

    Moskowitz, C. H.; Ribrag, V.; Michot, J. M.; Martinelli, G.; Zinzani, P. L.; Gutierrez, M.; De Maeyer, G.; Jacob, A. G.; Giallella, K.; Anderson, J. W.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Safety and early efficacy in an ongoing pilot study of brentuximab vedotin and AVD chemotherapy followed by 30 gray involved-site radiotherapy for newly diagnosed, early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Yahalom, J.; Schoder, H.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; Hamilton, A.; Hamlin, P.; Horwitz, S. M.; Jacob, A. G.; more...
    Blood (2014)

    Fulltext@MSK | Save